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SUMMARY
Aurora kinases (AURKs) are conserved serine/threonine kinases, crucial in regulating
cell cycle events. Mammalian oocytes express all three Aurk isoforms throughout
meiosis, withAurkA being the predominant isoform. Inhibition of all AURK isoforms by
pharmacological means disrupts oocyte meiosis. Therefore, AurkA short interfering
RNA (siRNA)was performed to silenceAurkA gene expression inmouse oocytes and
to further assess the functionofAurkAduringmeiosis byanalyzing subsequent loss-of
-function oocyte phenotypes. Results indicated that AurkA siRNA applied in our
experiments specifically knocked down both AurkA gene and protein expression
without influencing transcript levels of AurkB/AurkC and other endogenous protein
expression, such as GAPDH and ERK-2. AURKA was not essential for resumption of
meiosis, but it potentiated oocyte meiotic progression. Knockdown of AurkA led to a
significant reduction in the number of oocytes proceeding tometaphase II (MII).AurkA
siRNA resulted in abnormal spindle assembly, improper localization of microtubule
organizing centers (MTOCs) and misalignment of chromosomes in metaphase I (MI)
oocytes. Co-immunoprecipitations demonstrated that AURKA was physically asso-
ciated with phospho-Histone H3 ser10 in meiotic oocytes. AurkA siRNA dramatically
reducedHistoneH3 ser10 phosphorylation, but not ser28, and resulted in a significant
increase of abnormal chromosome segregation in MII oocytes. In conclusion, as a
predominant isoform among Aurks in oocytes, AurkA plays critical roles in mouse
oocyte meiosis by regulating spindle and chromosome dynamics.
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Aurora kinases (AURKs) are an evolutionary conserved
serine/threonine kinase family that plays a pivotal role in
regulating cell cycle dynamics. In mitosis, AURKs are
directly involved in regulation of mitotic entry, centrosome
Abbreviations: AURK, aurora kinase; dsRNA, double-stranded RNA; GVI,
germinal vesicle-intact; GVBD, germinal vesicle breakdown; IBMX, isobutyl-
methylxanthine; MI, metaphase I; MII, metaphase II; MTOC, microtubule orga-
nizing center; RNAi, RNA interference; RISC, RNA-induced silencing complex;
siRNA, short interfering RNA.
 2010 WILEY-LISS, INC.
maturation and separation, mitotic bipolar spindle assem-
bly, chromosome segregation and cytokinesis (Crane et al.,
2003; Ducat and Zhen, 2004; Meraldi et al., 2004). Three
AURK isoforms, A, B, andC, are characterized inmammals
based on their distinct subcellular localization and function
in the cell cycle (Crane et al., 2003). AURKB localizes to
chromosome kinetochores and themidbody duringmitosis,
and appears essential for chromosome condensation and
cytokinesis (Ditchfield et al., 2003; Goto et al., 2003).
AURKC is a chromosome passenger protein (Li et al.,
2004) that associates with AURKB and survivin in mitoti-
cally dividing cells (Yan et al., 2005). Finally, AURKA
localizes to centrosomes and spindle poles, and is primarily
responsible for centrosomematuration and separation, and
for bipolar spindle assembly during mitosis (Marumoto et
al., 2005; Ulisse et al., 2006). In addition, AURKA regulates
other important mitotic events, such as spindle checkpoint,
mitotic entry, kinetochore function, cytokinesis, cell asym-
metric division and cell fate determination (Barr and
Gergely, 2007). Both depletion and overexpression of Aur-
kA results in abnormal mitosis, and leads to genomic
instability, aneuploidy, and tumor formation (Anand et al.,
2003; Lu et al., 2008).
Though defined roles for AURKs exist for mitotically
dividing cells, their functional roles during oocyte meiosis
are just emerging. Accumulating evidence demonstrates
that AURKs regulatemeiotic progression, spindle dynamics
and chromosome remodeling in both lower vertebrate and
mammalian oocytes (Swain et al., 2008; Uzbekova et al.,
2008; Lane et al., 2010). All three Aurk isoforms are ex-
pressed inmammalian oocytes throughoutmeiotic progres-
sion (Swain et al., 2008;Uzbekovaet al., 2008; Shuda et al.,
2009). Inhibition of all three oocyte AURKs using inhibitor
ZM447439 results in meiotic arrest at a metaphase I (MI)-
like stage, displaying irregular spindle formation, inhibition
of histone H3 phosphorylation and abnormal chromosome
condensation (Swain et al., 2008; Eichenlaub-Ritter, 2009).
However, little information exists regarding the function of
individual Aurks during mammalian oocyte meiosis. A re-
cent paper using mRNA microinjection describes a role for
AURKC in mouse oocytes (Yang et al., 2010) and two
papers have attempted to delineate roles for AURKA. Yao
et al. (2004) utilized antibody neutralization in mouse oo-
cytes and found that AURKA inhibition interfered with oo-
cyte meiotic resumption and distorted MI spindle
organization. Saskova et al. (2008) reported that overex-
pression of AurkA led to the formation of an abnormal MI
spindle, while reduction of AurkA via long double-stranded
RNA (dsRNA) interfered with oocyte meiotic resumption
and spindle assembly. AlthoughAURKAwasdemonstrated
to co-localizewithMTOCsand chromosomesduring oocyte
meiosis (Yao et al., 2004; Saskova et al., 2008), no detailed
information regarding the impact of AurkA on MTOCs and
chromosome dynamics during oocyte meiotic progression
were reported, and the specificity of previously used knock-
down approaches is also questionable.
One method to determine function of specific intracellu-
lar regulators is RNAi. RNAi is a procedure that leads to
gene silencing through degradation of the target transcript
(Fire et al., 1998; Hammond et al., 2000). This mechanism
is initiated by dsRNA homologous to the gene being si-
lenced. The dsRNAs are processed by an enzyme named
Dicer to generate duplexes of 21 nt with 30-overhangs
called small interfering RNA, or siRNA. The siRNA assem-
bles into RNA-induced silencing complexes (RISCs) and
directly mediates the sequence-specific mRNA degrada-
tion (Meister and Tuschl, 2004; Mello and Conte, 2004).
Though fully grown oocytes progressing through meiosis
historically have been thought to be transcriptionally
inert, it has been confirmed that synthetic siRNA can be
delivered manually into oocytes during this developmental
period to silence specific genes (Svoboda et al., 2000;
Wianny and Zernicka-Goetz, 2000; Wang et al., 2007; Solc
et al., 2008). However, validation of specificity is crucial
before specific functions can be attributed to various genes,
especially in closely related genes such as the three Aurk
isoforms.
To begin to delineate Aurk isoform-specific function
during mammalian oocyte meiosis, AurkA siRNA was
microinjected into mouse oocytes to silence gene
expression, and specificity of the approach was thoroughly
validated to ensure no impact on other Aurk isoforms.
The functions of AurkA during mouse oocyte maturation
was then determined by examining loss-of-function pheno-
types, focusing on microtubule organizing center (MTOC)
arrangement, spindle organization, and chromosome
dynamics.
RESULTS
AurkA siRNA Specificity and the Influence on
Oocyte Meiotic Progression
AurkA siRNA specificity was determined on both AurkA
transcriptional and translational levels in germinal vesicle-
intact (GVI) oocytes just before re-initiation of meiosis with
IBMX withdrawal after 24 hr incubation. The real-time PCR
analysis demonstrated that, in comparison to control oo-
cytes, AurkA siRNA could specifically knockdown AurkA
transcript levels 59- to 67-fold (upper 98% efficiency) with-
out significantly affecting the other two Aurk isoforms
(AurkB and AurkC) (Fig. 1A); and Western blot analysis
further confirmed that AURKA protein expression levels
were dramatically reduced in oocytes before meiotic re-
sumption by AurkA siRNA, without significantly influencing
other oocyte endogenous protein expression, represented
by GAPDH and ERK2 assessments (Fig. 1B).
To determine if AurkA knockdown impacts oocyte mei-
otic resumption and progression, oocytes undergoing
GVBD and development to metaphase II (MII) in control
and AurkA siRNA groups were compared at 2 and 17 hr
after release from meiotic arrest, respectively. Results
demonstrate that AurkA knockdown had no significant
influence on oocyte meiotic resumption or GVBD. Rates
of GVBD were 94%, 95%, and 90% for buffer (n¼358),
non-targeted siRNA (n¼132), and AurkA siRNA (n¼355),
respectively (Table 1). However, AurkA knockdown signifi-
cantly reduced the rate of MII development (58%; P<0.05)
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compared to buffer (80%) and non-targeting siRNA (81%)
microinjection (Table 1).
MTOC Localization, Spindle Assembly, and
Chromosome Alignment in Metaphase I Oocytes
Confocal microscopic analysis showed that significantly
more (86%) of control MI oocytes (n¼ 30) possessed reg-
ular spindles with aligned chromosomes and bipolar
MTOCs (Fig. 2A) than AurkA siRNA MI oocytes (32%,
n¼ 35). Approximately 68% of AurkA siRNA oocytes
showed irregular MI spindles with their MTOC improperly
localized and their chromosomes misaligned (Fig. 2B,
P<0.01). Unlike control oocytes containing irregular MI
spindles with the random appearance of mislocalized
MTOCs or scattered chromosomes or both improperly
localized MTOCs and chromosomes, AurkA siRNA oocyte
containing irregular spindles normally accompanied mis-
aligned chromosomes and improperly localized MTOCs.
Our additional analysis examining structural components of
MTOCs through co-localization of twomajor components, g
-tublin and pericentrin, further confirmed that AurkA knock-
down significantly disrupted the bipolar localization of
MTOCs and resulted in MTOCs scattered around the spin-
dle area in MI oocytes (Fig. 2C).
Oocyte Chromosome Segregation
AurkA knockdown led to a significant increase in MII
oocytes with abnormal chromosome segregation (42%
total; 34% hyperploidy þ8% hypoploidy, n¼38) compared
to controls (25% total; 18% hyperploidy þ7% hypoploidy,
n¼ 56,P<0.05; Fig. 3A), and resulted in oocyte aneuploidy
(Fig. 3B).
AURKA and Phospho-Histone H3 ser10 During
Meiosis and Mitosis
To identify a substrate for AURKA that may explain the
observed phenotypic defects following siRNA and to
determine if AurkA can specifically influence chromosome
dynamics up to MII, we analyzed oocyte histone H3 phos-
phorylation following AurkA siRNA. Results demonstrated
thatAurkA knockdown inhibitedhistoneH3phosphorylation
at ser-10, but had no effect on the phosphorylation on the
ser-28 (Fig. 4A,B).
To further confirm that AURKA is directly involved in the
histone H3 phosphorylation under physiological conditions,
coimmunoprecipitation using phospho-histone H3 ser10 an-
tibody was performed in both meiotic oocytes and mitotic
KGN cells. Our results demonstrate that AURKA can be
specifically coimmunoprecipitated by phospho-histone H3
ser10antibody in bothmitoticKGNcells (Fig. 4C) and in vivo-
matured MII oocytes (Fig. 4D), while other proteins, like b-
tubulin, could not be coimmunoprecipitated under the
same experimental condition. Since knockdown of AURKA
caused inhibition of histone H3 ser10 phosphorylation, we
concluded that AURKA acts as a histone H3 ser10 kinase in
oocytes.
Figure 1. A:AurkA transcript level was significantly reduced inAurkA
siRNA injected oocytes compared with buffer and non-targeting
siRNA injected controls (P<0.01), whereas AurkB and AurkC tran-
script levels are not significantly influenced. Data are presented as
meanSEM and statistical significance was determined using un-
paired Student’s t-test, P<0.01. Oocyte samples were collected at
the GVI stage just before re-initiation of meiosis with IBMX withdraw-
al. B: Representative Western blot analysis demonstrating that AUR-
KA protein expression was significantly knocked down by AurkA
siRNA, but not with non-targeting siRNA or buffer injection. Equal
numbers of GVI oocytes were loaded (n¼130 each lane). Experi-
ments were repeated three times.
TABLE 1. Comparison of Germinal Vesicle Breakdown and MII Development in Control and AurkA Knockdown Oocytes
GVBDSEM (%)
2 hr after meiotic resumption
MIISEM (%)
17hr after meiotic resumption
Buffer control oocytes (n¼ 358) 94 1.7a 80 3.0b
Nontargeting siRNA oocytes (n¼ 132) 95 0.84a 81 1.6b
AurkA siRNA oocytes (n¼ 355) 90 1.7a 58 3.0c
All data were averaged and based on at least three independent experiments and expressed as a meanSEM. Data were statistically analyzed by unpaired Student
t-test. Different superscripts (a, b, and c) within a column indicate significant differences between treatments, P<0.05.
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DISCUSSION
AURKA has been localized to nuclei in GV-intact mouse
oocytes; co-localized with MTOCs and condensing chro-
mosomes at prophase oocytes; found at the spindle pole,
MTOCs and condensed chromosomes in MI oocytes (Yao
et al., 2004; Saskova et al., 2008); and further concentrated
to spindle poles at MII oocytes (Yao et al., 2004). Recent
comparative studies on levels of three Aurk isoform tran-
scripts demonstrated that AurkAwas the predominant form
in meiotic competent bovine and mouse oocytes, and its
transcript levels were much higher than AurkB and AurkC
(Swain et al., 2008; Uzbekova et al., 2008; Shuda et al.,
2009). These data suggest a crucial role of AurkA among
the three isoforms in regulating the progression of oocyte
meiosis in mammals.
In this study, mouse AurkA sequence-specific siRNA
was utilized to assess the function of AurkA during mouse
oocyte meiosis. Importantly, results demonstrated that
AurkA siRNAcould specifically inhibitAurkAgene transcrip-
tion and translation without influencing AurkB, AurkC tran-
script levels. Furthermore, because no AURKB or AURKC
antibodies could be found to give reliable results in mouse
oocytes, we also utilized GAPDH and ERK-2 antibodies as
Figure 2. A:AurkA knockdown inmouse oocytes results in a significant reduction in normal spindle and
chromatin formation/alignment in MI oocytes (86% vs. 32%). Statistical significance was determined
using Chi-square analysis, P<0.01. B: Representative micrographs resulting from confocal micro-
scopic analysis demonstrating AurkA knockdown lead to improper localization of MTOCs (pericentrin,
red), misaligned chromosomes (Hoechst, blue) and irregular shaped spindles (b-tubulin, green) in MI
oocytes cultured for 7 hr. C: Additional analysis on impact of AurkA siRNA on MTOC structure.
Representative micrographs using confocal microscopic analysis examining co-localization of key
structural proteins, g-tubulin (green) and pericentrin (red), with and without AurkA siRNA.
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indicators to verify that endogenous protein levels in our
experiment were not impacted by AurkA siRNA. In contrast,
two prior studies examiningAurkA function in oocytes using
antibody neutralization (Yao et al., 2004) and long double
strand AurkA RNAi (Saskova et al., 2008), failed to ensure
that the antibody and dsRNAi applied in their experiments
were Aurk isoform-specific and had no impact on overall
endogenous protein expression. For instance, antibody
neutralization studies utilized rabbit IgG injected oocytes
as controls, but no further experiments were performed to
confirm the specificity of AurkA antibody (Yao et al., 2004)
while AurkA RNAi studies usedGFP dsRNA as controls but
did not confirm whether AurkA dsRNA impacted transcript
levels of Aurk B and C (Saskova et al., 2008). Lack of
specificity in prior studies may be one explanation for
observed differences between studies. Use of rescue stud-
ies utilizing AurkA, similar to those conducted with AurkB
(Shuda et al., 2009), could help validate findings.
Developmental data demonstrated that AurkA is not
essential for spontaneous oocyte meiotic resumption
(e.g., GVBD). Though both AurkA transcript and protein in
GVI oocytes before meiotic resumption were significantly
reduced after 24 hr AurkA siRNA process, oocyte meiotic
resumption/GVBD did not differ significantly from controls.
This result is in agreement with the findings that inhibition of
bovine and mouse oocyte AURKs with inhibitors VX680 or
ZM447439, which inhibit all AURKs, had no significant
impact on oocyte GVBD (Swain et al., 2008; Uzbekova
et al., 2008). This is also well supported by the recent report
that overexpression of AurkA could not override the inhibi-
tory effect on oocyte meiotic resumption caused by high
cAMP level (Saskova et al., 2008), while other essential
factors (cdc25A and cdc25B) could promote GVBD under
similar culture conditions (Solc et al., 2008).However, these
results are in contrast to the previous work presented by
Yao et al. (2004) and Saskova et al. (2008) who demon-
strated that microinjecting AURKA antibody or AurkA long
double strand RNA in mouse oocytes inhibited oocyte
GVBD. As mentioned, variations in technique or lack of
specificity of antibody or RNAi could explain these
differences.
Though AurkA knockdown had no impact on meiotic
resumption/GVBD at 2 hr, AurkA siRNA did lead to a signif-
icant reduction in the number of oocytes proceeding to MII
and extruding the first polar body after 17 hr of in vitro
maturation. This result is consistent with other studies
examining roles for all Aurks or AurkA in oocytes (Yao et
al., 2004; Saskova et al., 2008; Swain et al., 2008; Uzbe-
Figure 3. A: AurkA knockdown significantly inhibits normal chromosome segregation in oocytes, as
42% of MII oocytes displayed abnormal chromosome complement compared to 25% of controls.
Statistical significance was determined using Chi-square analysis, P<0.05. B: Representative chro-
mosome spreadmicrographs demonstrating the aneuploidies observed inMII oocytes cultured for 17 hr
after AurkA knockdown (n¼ number of chromosomes in image).
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kovaet al., 2008). This inhibitionmaybedue todirect effects
on chromosomes or to regulation of the meiotic spindle and
its components during earlier stages of meiosis, such as
microtubules or MTOCs.
Previous reports indicate that AurkA directly regulates
centrosome functions in mitotic cells (Crane et al., 2003;
Barr and Gergely, 2007). In mouse oocytes, there are no
centrosome structures with centrioles, rather MTOCs are
reported to function like centrosomes (Schuh and Ellen-
berg, 2007). AURKA co-localizes with MTOCs during the
entire meiotic process in mouse oocytes (Yao et al., 2004;
Saskova et al., 2008). This tight structural connection
suggests that AURKA may also be functionally associated
with MTOCs during oocyte meiosis. Our siRNA studies
demonstrated that AurkA knockdown disrupts MTOC loca-
tion in MI oocytes. To further explore the influence of AurkA
on MTOCs, we stained MI oocytes for two MTOC proteins,
gamma tubulin and pericentrin, and examined MTOC or-
ganization. Our confocal microscopic analysis is the first
evidence demonstrating that highly specificAurkA siRNA in
mouse oocytes indeed disrupts the proper localization of
these key MTOC proteins. Instead of bipolar localization,
MTOCs in AurkA knockdown oocytes were scattered in the
middle part of the spindle area. Recent studies indicated
that MTOC self-organization and polar migration or pole
ejection was critical to bipolar spindle assembly in mouse
oocytes (Schuh and Ellenberg, 2007). Therefore, this im-
proper localization of MTOCs might cause the aberrant
spindle assembly inMIAurkA siRNA oocytes. Interestingly,
evidence suggests that AURKA is an activator of Kinesin-5
(Eg-5) (Crane et al., 2003; Barr and Gergely, 2007), and
activation of Eg-5 is a critical regulator of pole ejection and
spindle bipolarization in mouse oocytes (Schuh and Ellen-
berg, 2007).
In addition to its localization with MTOCs, AURKA was
also found to co-localize with chromosomes during mouse
oocyte meiosis (Yao et al., 2004; Saskova et al., 2008).
AURKA initially localized in nuclei before meiotic resump-
tion, then associated with condensing chromatin after
GVBD (Yao et al., 2004). Like MTOCs, this structural
correlation also suggests a potential role of AurkA in regu-
lating chromatin remodeling during oocyte meiosis. In sup-
port of this developmental pathway, immunocytochemistry
and chromosome spreads demonstrated that AurkA siRNA
significantly increased thenumber of oocyteswith abnormal
spindles and chromosome segregation or misalignment on
the metaphase plate. Though we only examined MI devel-
opment at 7 hr, there is little reason to think that observed
alignment defects were simply due to delayed meiosis. No
delay was observed in GVBD and observed defects were
severe, unlike organizational structuring of the oocyte mei-
otic spindle at other time points reported in the existing
literature.
It should be noted that our chromosome analysis experi-
ment did yield an 25% aneuploidy rate in vehicle micro-
injected control oocytes, which is much higher than those in
the naturally in vivo matured MII oocytes (Hunt et al., 2003;
Liu et al., 2008). As evidenced by the elevated hyperploidy
rate, this high aneuploidy rate is not due to chromosome
loss (hypoploidy) that sometimes occurs during the fixation
process. Possible explanations for the elevated rates of
aneuploidy observed in control oocytes include the use of
equine chorionic gonadotropin (eCG) and/or follicle stimu-
lating hormone (FSH) treatment, which has been reported
to increase MII oocyte aneuploidy (Sato and Marrs, 1986;
Roberts et al., 2005). Furthermore, there may be an impact
from the act of microinjection as well as 24 hr IBMX incuba-
tion. Recent publications, however, also demonstrated no
dramatic impact on oocyte aneuploidy after FSH treatment
(Duncan et al., 2009; Chiang et al., 2010; Lane et al., 2010)
or even microinjection (Reis et al., 2007). Importantly, our
current experiment was carefully controlled, as both control
and AurkA siRNA oocytes were manipulated under the
same conditions and the rates of aneuploidy in AurkA
siRNA MII oocytes were statistically significantly higher
Figure 4. A: Representative Western blot and (B) desitometric anal-
ysis demonstrating that AurkA knockdown significantly inhibited the
phosphorylation of histone H3 at ser-10, but not at ser-28. Equal
numbers of oocytes (n¼120) were loaded in each lane and the
membrane was stripped and re-probed for ERK-2 and GAPDH.
Experiments were repeated three times. C,D: Representative
co-immunoprecipitation results demonstrating that AurkA can be
specifically co-immunoprecipitated by phospho-histone H3 ser10
antibody in (C) KGN cells and (D) MII oocytes (n¼283/lane), while
b-tubulin cannot.
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than those in control oocytes. Thus,we conclude thatAurkA
siRNA induced MII oocyte aneuploidy.
In an effort to explain how AurkA regulates oocyte
chromosome dynamics, histone H3 phosphorylation was
investigated. Inhibition of histone H3 phosphorylation, es-
pecially histone H3 ser10 and ser28 phosphorylatyion,
is essential in controlling chromosome condensation/
segregation in mitotic cells or mammalian oocytes (Wei et
al., 1999; Hsu et al., 2000; Bui et al., 2004; Wang et al.,
2006; Swain et al., 2007, 2008). Importantly, AURKA is a
potent histoneH3 ser10 kinase inmitotic cells (Crosio et al.,
2002). Our Western blot analysis revealed that AurkA
knockdown significantly inhibited histone H3 ser10, but not
ser28, phosphorylation in oocytes. Our coimmunoprecipi-
tation further demonstrate, for the first time, that AURKA
specifically interacts with phospho-histone H3 ser10 in
mammalian oocytes. This is interesting, considering that
the previous studies using pharmacologic inhibitors of all
AURKs inhibited histoneH3 phosphorylation on both ser 10
and ser 28 (Swain et al., 2008). We therefore conclude that
AURKA is acting as a histone H3 ser10 kinase in meiotic
oocytes, while either AURKB or AURKC regulate Ser28
phosphorylation. However, it should be noted that both
AURKB and AURKC may also play a role in ser10 phos-
phorylation. AURKBhas been shown to regulate both ser10
and ser28 in mitotic cell extracts (Goto et al., 2003), and its
localization to condensed chromatin in oocytes suggests a
possible role in meiosis as well. While AURKB has been
reported in bovine oocytes (Jelinkova and Kubelka, 2006),
conflicting results exists in regard to its presence in mouse
oocytes (Shuda et al., 2009; Yang et al., 2010). Previous
studies attempting to examine AURKB function in oocytes
rely on the use of low doses of broad pharmacologic
inhibitors, which inhibit all AURKs and thus make it impos-
sible to designate any specific roles for AURKB (Jelinkova
and Kubelka, 2006; Shuda et al., 2009; Lane et al., 2010),
though over expression of AurkB did rescue defects in
chromosome alignment following broad AURK inhibition
using ZM447439 (Shuda et al., 2009). Additionally, AURKC
was found to regulate histone H3 ser10 phosphorylation
during mouse oocyte meiosis, though the specificity of the
AURKC knockdown approach was not validated and the
impact on AURKA levels were not examined (Yang et al.,
2010). Thus, it is possible that a redundancy system exists,
which permit multiple AURKs to regulate ser10 phosphory-
lation. It is also important to note that other relevant sub-
strates likely exist that help explain observed chromosomal
defects following AurkA knockdown. AURKA phosphory-
lates several other proteins, such as the kinetochore-spe-
cific protein CENP-A inmitotic cells due to a sequencemotif
similarity to the phosphorylation motif of histone H3 ser10
(Zeitlin et al., 2000). Inhibition of CENP-A phosphorylation
resulted in chromosomalmisalignment onmetaphase plate
in mammalian cells (Cleveland et al., 2003; Kunitoku et al.,
2003). Future studies examining additional substrates of
AURKA may be informative.
In summary, these studies describe functional roles for
AurkA in mouse oocyte meiosis utilizing a highly specific
siRNA approach. AurkA did not appear to be essential for
oocytemeiotic resumption; however, it did play a crucial role
in regulating mouse oocyte meiotic progression, with re-
duced AURKA levels disrupting spindle assembly, chromo-
somal alignment, and normal chromosome segregation
when protein levels were reduced. This is the first report
demonstrating a critical role for AurkA in proper oocyte
MTOC organization/localization, as well as being a histone
H3 kinase that regulates histone H3 activity through ser10
phosphorylation. Because of the apparently high overlap
between all 3 Aurk isoforms in their targets and observed
phenotypes, future studies must be careful to confirm
specificity of knockdown approaches. Future studies will
focus on additional substrates of AurkA involved in regula-
tion of MTOC localization/organization.
MATERIALS AND METHODS
All procedures described within were reviewed and ap-
proved by The University Committee on Use and Care of
Animals at the University of Michigan, and were performed
in accordance with the Guiding Principles for the Care and
Use of Laboratory Animals.
Mouse Stimulation and Oocyte Collection
Female CF-1 mice (Harlan, Indianapolis, IN), 20–
21 days old, were primed with 5 IU equine chorionic go-
nadotropin (eCG) (Sigma, St. Louis, MO), and fully-grown,
meiotically competent germinal vesicle intact (GVI) oocytes
were collected after 42–44 hr hormone stimulation. Cumu-
lus-enclosedoocyteswere isolatedbymanually rupturingof
antral follicles in human tubual fluidþHepesmedia (HTFH;
Irvine Scientific, Santa Ana, CA) supplemented with 0.3%
bovine serum albumin (BSA) and 40mM isobutylmethyl-
xanthine (IBMX) (Sigma) to maintain meiotic arrest for
subsequent siRNA. Oocytes were then denuded, washed,
and kept in HTF/0.3% BSA/40mM IBMX at 37C, 5% CO2
and air incubator prior to microinjection.
AurkA siRNA Designing, Synthesis, Preparation,
and Microinjection
AurkA siRNA was designed based on the NCBI mouse
AurkA sequence (NM_011497.2) using Dharmacon
Customer Chicago, IL siRNA Design Tool and synthesized
by Dharmacon (Chicago, IL) siRNA Technologies.
50ATACGTACCAGGAGACTT Att 30; 30ttTATGCATGGTCC
ttTATGCATGGTCC T CTGAAT 50. The nontargeting,
scrambled siRNA was purchased from Dharmacon
(D001210-01-05). Both AurkA siRNA and nontargeting siR-
NA were reconstituted in Dharmacon siRNA buffer to a final
concentration of 20mM and stored at80C until utilization.
Approximately 20 pl AurkA siRNA, nontargeting siRNA
or Dharmacon siRNA buffer was microinjected into the
cytoplasm of denudedGVI oocytes, and cells were cultured
for 24 hr in HTF/0.3% BSA/60mM IBMX to prevent meiotic
progression and to allow for siRNA processing. Themeiotic
inhibitor IBMX was removed after triple washing in HTFHþ
0.3%BSAmedia, andoocyteswereallowed toproceedwith
meiosis in HTFþ 0.3% BSA in a 5% CO2 incubator for 2 hr
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to assess germinal vesicle breakdown (GVBD), 7 hr to
assess metaphase I (MI) development, and 17 hr to cate-
gorize metaphase II (MII) development. Data were collect-
ed from three different individual experiments. The number
of GVBD and MII oocytes was calculated and analyzed
statistically.
Total RNA Isolation, Reverse Transcription, and
Real-time PCR
Total RNA was extracted from 20 oocytes in buffer,
nontargeting siRNAandAurkA siRNAmicroinjected groups
respectively using Picopure RNA Isolation kit (Arcturus
Bioscience, Mountain View, CA) following manufacturer’s
instructions.Oocyte cDNAwas synthesized using 125 pmol
randomhexamer, 500mMdNTP, 20 IURNase inhibitor and
62.5 IU MultiScribe reverse transcriptase (ABI systems)
in a final volume of 50ml. Primers for mouse AurkA, AurkB,
and AurkC were designed with no sequence overlap be-
tween isoforms (Swain et al., 2008). Real-time PCR was
performed on Applied Biosystems 7300 Real-Time PCR
system using SYBR Green PCR Master Mix (Applied Bio-
Systems, Foster City, CA). Each PCR reaction was per-
formed with 1.5 oocyte equivalents of cDNA. Real-time
PCR reactions were carried out for 40 cycles (95C for
15 sec, 60C for 1min) after initial 10min incubation at
95C. Data were collected over three replicates with tripli-
cate samples for each isoform. Fold decreases were based
on the transcript level of AurkA in siRNA microinjected
oocytes, which were normalized to 1. Comparative Ct
method was used for data analysis and b-actin was used
for internal control. Statistical significance was determined
using the unpaired Student’s t-test.
Western Blot Analysis
Western blot analysis was performed to determine the
effects of AurkA siRNA on the protein expression levels of
AURKA and other downstream signaling molecules. Be-
cause nontargeted siRNA and vehicle microinjection were
similar in lack of influence on Aurk expression and meiotic
progression, subsequent studies were performed with ve-
hiclemicroinjection as control. Equal numbers ofMI andMII
oocytes in control and AurkA knockdown groups were
compared. Oocytes were placed in Laemmli Sample Buffer
(Bio-Rad Laboratories, Hercules, CA) according to man-
ufacturer’s instruction, vortexed and placed on ice for
15min. Following sonication on ice for 10 sec, samples
were denatured at 90C for 10min and loaded on 12% gel
for electrophoresis. Total protein from equal numbers
of mouse oocytes in control and AurkA knockdown
groups was loaded in each lane and separated by one-
dimensional SDS–PAGE. Gels were equilibrated and
transferred to Hybond-P PVDF transfer membrane
(Amersham Life Sciences, Little Chalfont Buckingham-
shire, UK) by Semi-Dry Electrophoretic Transfer Cell (Bio
-Rad Laboratories) according to themanufacturer’s instruc-
tions. Blots were blocked in 5% nonfat milk in Tris-buffered
saline (TBS) with 0.1%Tween (TBST) at room temperature
for 1 hr, and incubated with the appropriate primary anti-
body diluted in TBST/5%BSA at least overnight at 4Cwith
agitation. The antibodies included anti-AURKA (1:500, Cell
Signaling, Danvers, MA), anti-phospho-ser10-histone H3
(1:500, Cell Signaling), anti-phospho-ser 28-histone H3
(1:500, Upstate, Billerica, MA), anti-ERK-2 (1:1,000, Santa
Cruz, Santa Cruz, CA) and anti-GAPDH (1:1,000, Novus,
Littleton, CO). After complete washing in TBST, blots were
incubatedwith appropriate peroxidase-conjugated IgGsec-
ondary antibody (Amersham Life Sciences) at room tem-
perature for 2 hr, washed in TBST and developed with ECL
Plus reagents (Amersham Life Sciences) according to the
manufacturer’s instructions. Membranes were re-probed
using different primary antibodies after stripping at 50C
for 30min in stripping buffer (62.5M Tris–HCl, pH 6.7, 2%
SDS, and 100mM b-mercaptoethanol).
Immunocytochemistry and Confocal
Microscopic Analysis
To examine the effect of AurkA siRNA on spindle forma-
tion, MTOC localization and chromosomal alignment, MI
oocytes in control and knockdown groups were attached to
poly-lysine coated coverslips separately, fixed in 2% (w/v)
paraformaldehyde for 1 hr at 37C, blocked overnight with
PBST/0.3% BSA at 4C and incubated with primary anti-
bodies at 37C for 1 hr. Antibodies used for experiments
included anti-b-tubulin to visualize microtubules (Sigma,
1:200); anti-pericentrin (Covance, Princeton, NJ, 1:200)
and g-tubulin (Sigma, 1:100) to visualize MTOCs. Chroma-
tinwas stainedwithHoechst 33342 (5mg/ml). After washing
of primary antibodies, samples were reacted with the ap-
propriate Alexa568 and 488 conjugated secondary antibo-
dies (Molecular Probes, Carlsbad, CA) at a 1:1,000 dilution
for 1 hr at 37C. Coverslips were then mounted on glass
slides for visualization under 1,000 confocal microscope
(Olympus Fluoview 500). For confocal microscopic analy-
sis, Z-stacks were captured with 0.3mm steps through the
entire spindle, MTOC, and chromosome area in each oo-
cyte, then imageswere reconstituted viaFluoviewsoftware.
Imageswere taken and graded in blinded fashion as normal
or abnormal. Criteria included normal shaped barrel spindle
formation, proper localization of chromatin on the meta-
phase plate, and proper localization of MTOC proteins
(pericentrin and g-tubulin) at the spindle poles.
Chromosome Analysis
Metaphase II oocytes matured for 17 hr in control and
knockdown groups were collected and chromosomal
spreads prepared using 1% paraformaldehyde method
(Hodges and Hunt, 2002) with slight modification. All treat-
ments from the same day were prepared side-by-side to
control for variability. Briefly, zona pellucidae of oocytes
were removed by 0.6% proteinase K in PBS. Zona-free
oocytes were then washed, treated with hypotonic buffer
(0.075M KCl) for 5min, and fixed onto a microscope slide
dipped in the solution of 1% paraformaldehyde/3mM DTT/
0.15% TritonX-100 (pH 9.2). Slides were then placed into
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humidified chambers overnight, air dried at room tempera-
ture, stained by 5mg/ml Hoechst 33342 for 5min, triple
washed with 1PBS and mounted in glycerol mounting
solution. Chromosomal spreads were analyzed at 1,000
on a Leica DMR microscope and images taken so that the
chromosome numbers could be counted in a treatment
blinded fashion. Numbers of chromosomes were counted
to determine segregation errors and data was statistically
analyzed.
Co-Immunoprecipitation
To determine if AURKA was directly involved in the
phosphorylationof histoneH3under physiological condition
in cells and oocytes, co-immunoprecipitation experiments
using phospho-histoneH3 (ser10) antibody (Cell Signaling)
were performed in MII oocytes and the human granulosa-
like tumor cell line, KGN, following manufacture’s instruc-
tion. Briefly, MII oocytes (n¼ 566) were collected from
superovulated CF1 mice (8 weeks old) and KGN cells
cultured in 75 cm2 flask were harvested at their 90% con-
fluence. Both cells were triple washed with cold 1PBS
before transferring to or scrapping off in ice cold 1 cell lysis
buffer [20mM Tris (pH 7.5), 150mM NaCl, 1mM EDTA,
1mM EGTA, 1% Triton X-100, 2.5mM Sodium pyrophos-
phate, 1mM b-glycerophosphate, 1mM Na3VO4 with pro-
teinase inhibitor cocktail (Roche, Indianapolis, IN)]. Cells
were sonicatedon ice five times for 10 seceach, centrifuged
at 12,000g for 10min at 4C, and their supernatants were
recovered for co-IP experiment. The supernatants were
divided into two equal parts and 1PBS or phospho-
Histone H3 (ser10) antibody were added, respectively, in
control or Co-IP groups (1:50 dilution), and incubated over-
night at 4C with gentle rocking. The following day, pre-
washed protein A agarose beads (50% slurry, Millipore,
Billerica,MA)were added into each group, incubated at 4C
with gentle rocking for 3 hr, then pelleted down at 12,000g
for 30 sec at 4C. The eluted supernatants were kept for
Western blot analysis later and protein A agarose beads
pellets were washed with 500ml lysis buffer for four times at
4C, then 3SDS sample buffer added and heated at
95–100C for 5min. Western blot analysis was carried out
as described. Thewhole KGN cell lysatewas served as non
-IP control. Experiments were repeated twice.
Statistical Analysis
Unpaired Student t-test and Chi-square analysis was
performed, as indicated in results, table or the figure le-
gends, using GraphPad Software. Differences of P<0.05
were considered to be significant.
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